Nina Kimer

1.3k total citations
56 papers, 786 citations indexed

About

Nina Kimer is a scholar working on Hepatology, Epidemiology and Surgery. According to data from OpenAlex, Nina Kimer has authored 56 papers receiving a total of 786 indexed citations (citations by other indexed papers that have themselves been cited), including 44 papers in Hepatology, 41 papers in Epidemiology and 22 papers in Surgery. Recurrent topics in Nina Kimer's work include Liver Disease and Transplantation (43 papers), Liver Disease Diagnosis and Treatment (40 papers) and Organ Transplantation Techniques and Outcomes (13 papers). Nina Kimer is often cited by papers focused on Liver Disease and Transplantation (43 papers), Liver Disease Diagnosis and Treatment (40 papers) and Organ Transplantation Techniques and Outcomes (13 papers). Nina Kimer collaborates with scholars based in Denmark, Germany and United States. Nina Kimer's co-authors include Lise Lotte Gluud, Flemming Bendtsen, Søren Møller, Aleksander Krag, E. Dahl, Lise Hobolth, Maja Thiele, Hendrik Vilstrup, Mette Munk Lauridsen and Julie Steen Pedersen and has published in prestigious journals such as PLoS ONE, Hepatology and The Journal of Clinical Endocrinology & Metabolism.

In The Last Decade

Nina Kimer

50 papers receiving 767 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Nina Kimer Denmark 15 569 564 279 95 69 56 786
Alessandra Brocca Italy 17 468 0.8× 495 0.9× 215 0.8× 79 0.8× 107 1.6× 32 837
Chavdar S Pavlov Russia 18 688 1.2× 455 0.8× 179 0.6× 76 0.8× 41 0.6× 84 937
Elisabet García Spain 11 487 0.9× 681 1.2× 289 1.0× 60 0.6× 162 2.3× 17 894
Aylin Tansel United States 11 375 0.7× 286 0.5× 340 1.2× 22 0.2× 39 0.6× 24 734
Hugh Watson Denmark 16 754 1.3× 949 1.7× 449 1.6× 88 0.9× 70 1.0× 47 1.3k
Zachary Henry United States 13 359 0.6× 428 0.8× 278 1.0× 22 0.2× 29 0.4× 51 769
J Chesta Chile 12 514 0.9× 616 1.1× 248 0.9× 31 0.3× 59 0.9× 28 745
Habeeb Salameh United States 11 412 0.7× 348 0.6× 277 1.0× 68 0.7× 15 0.2× 21 784
Ezequiel Rodríguez Spain 14 560 1.0× 907 1.6× 383 1.4× 39 0.4× 181 2.6× 20 1.1k
Ji-Tseng Fang Taiwan 15 322 0.6× 324 0.6× 205 0.7× 27 0.3× 55 0.8× 20 642

Countries citing papers authored by Nina Kimer

Since Specialization
Citations

This map shows the geographic impact of Nina Kimer's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Nina Kimer with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Nina Kimer more than expected).

Fields of papers citing papers by Nina Kimer

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Nina Kimer. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Nina Kimer. The network helps show where Nina Kimer may publish in the future.

Co-authorship network of co-authors of Nina Kimer

This figure shows the co-authorship network connecting the top 25 collaborators of Nina Kimer. A scholar is included among the top collaborators of Nina Kimer based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Nina Kimer. Nina Kimer is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Møller, Søren, Karen Vagner Danielsen, Lise Hobolth, Christian Mortensen, & Nina Kimer. (2025). Diagnosis of Portal Hypertension. Diagnostics. 15(21). 2774–2774.
2.
Zawadzki, Andressa de, Nina Kimer, Troels M. Busk, et al.. (2025). The heterogeneity of cirrhosis - systemically assessed endotypes described by fibrosis, apoptosis, and immunoregulatory-related biomarkers. Digestive and Liver Disease. 57(7). 1442–1450.
3.
Kimer, Nina, et al.. (2025). Editorial: Dysfunctional Neutrophils in Cirrhosis With Acute Decompensation: Why It Matters. Alimentary Pharmacology & Therapeutics. 63(7). 1046–1047.
4.
Werge, Mikkel Parsberg, Nina Kimer, Anders Junker, et al.. (2024). Use of PNPLA3, TM6SF2, and HSD17B13 for detection of fibrosis in MASLD in the general population. Clinics and Research in Hepatology and Gastroenterology. 48(7). 102389–102389. 5 indexed citations
5.
6.
Lauridsen, Mette Munk, Lea Ladegaard Grønkjær, J. Atkins, et al.. (2024). Portosystemic Hepatic Encephalopathy Scores (PHES) differ between Danish and German healthy populations despite their geographical and cultural similarities. Metabolic Brain Disease. 39(6). 1149–1155. 1 indexed citations
7.
Gao, Qian, Kajetan Trôst, Henriette Ytting, et al.. (2023). Low sphingolipid levels predict poor survival in patients with alcohol-related liver disease. JHEP Reports. 6(2). 100953–100953. 4 indexed citations
8.
Webel, Henry, Karen Vagner Danielsen, Lise Hobolth, et al.. (2023). Markers of inflammation predict survival in newly diagnosed cirrhosis: a prospective registry study. Scientific Reports. 13(1). 20039–20039. 6 indexed citations
9.
Bendtsen, Flemming, et al.. (2023). Nurse-assisted and multidisciplinary outpatient follow-up among patients with decompensated liver cirrhosis: A systematic review. PLoS ONE. 18(2). e0278545–e0278545. 8 indexed citations
10.
Kimer, Nina, Ole Hamberg, Allan M. Lund, et al.. (2022). The impact of rifaximin on inflammation and metabolism in alcoholic hepatitis: A randomized clinical trial. PLoS ONE. 17(3). e0264278–e0264278. 23 indexed citations
11.
Jørgensen, Niklas Rye, et al.. (2021). Patients With Cirrhosis Have Elevated Bone Turnover but Normal Hepatic Production of Osteoprotegerin. The Journal of Clinical Endocrinology & Metabolism. 107(3). e980–e995. 6 indexed citations
12.
Kimer, Nina, Henning Grønbæk, Rikard G. Fred, et al.. (2020). Atorvastatin for prevention of disease progression and hospitalisation in liver cirrhosis: protocol for a randomised, double-blind, placebo-controlled trial. BMJ Open. 10(1). e035284–e035284. 7 indexed citations
13.
Kimer, Nina, Lise Lotte Gluud, Julie Steen Pedersen, et al.. (2020). The Psychometric Hepatic Encephalopathy Syndrome score does not correlate with blood ammonia, endotoxins or markers of inflammation in patients with cirrhosis. Translational Gastroenterology and Hepatology. 6. 8–8. 11 indexed citations
14.
Kimer, Nina, N.S. Gudmann, Julie Steen Pedersen, et al.. (2018). No effect of rifaximin on soluble CD163, mannose receptor or type III and IV neoepitope collagen markers in decompensated cirrhosis: Results from a randomized, placebo controlled trial. PLoS ONE. 13(9). e0203200–e0203200. 5 indexed citations
15.
Kimer, Nina, et al.. (2016). Advances in the treatment of portal hypertension in cirrhosis. Expert Review of Gastroenterology & Hepatology. 10(8). 1–9. 5 indexed citations
16.
Gluud, Lise Lotte, Nina Kimer, & Aleksander Krag. (2014). Safety, efficacy, and patient acceptability of rifaximin for hepatic encephalopathy. Patient Preference and Adherence. 8. 331–331. 20 indexed citations
17.
Lauridsen, Mette Munk, Maja Thiele, Nina Kimer, & Hendrik Vilstrup. (2013). The continuous reaction times method for diagnosing, grading, and monitoring minimal/covert hepatic encephalopathy. Metabolic Brain Disease. 28(2). 231–234. 60 indexed citations
18.
Dahl, E., Lise Lotte Gluud, Nina Kimer, & Aleksander Krag. (2012). Meta‐analysis: the safety and efficacy of vaptans (tolvaptan, satavaptan and lixivaptan) in cirrhosis with ascites or hyponatraemia. Alimentary Pharmacology & Therapeutics. 36(7). 619–626. 52 indexed citations
19.
Kimer, Nina, E. Dahl, Lise Lotte Gluud, & Aleksander Krag. (2012). Antiviral therapy for prevention of hepatocellular carcinoma in chronic hepatitis C: systematic review and meta-analysis of randomised controlled trials. BMJ Open. 2(5). e001313–e001313. 23 indexed citations
20.
Kimer, Nina, Palle Nordblad Schmidt, & Aleksander Krag. (2010). Cameron lesions: an often overlooked cause of iron deficiency anaemia in patients with large hiatal hernias. BMJ Case Reports. 2010. bcr0620103129–bcr0620103129. 17 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Alessandra Brocca Breakdown of academic impact, for papers by Chavdar S Pavlov Breakdown of academic impact, for papers by Elisabet García Breakdown of academic impact, for papers by Aylin Tansel Breakdown of academic impact, for papers by Hugh Watson Breakdown of academic impact, for papers by Zachary Henry Breakdown of academic impact, for papers by J Chesta Breakdown of academic impact, for papers by Habeeb Salameh Breakdown of academic impact, for papers by Ezequiel Rodríguez Breakdown of academic impact, for papers by Ji-Tseng Fang
Rankless by CCL
2026